Clinical Lab Product's May Podcast SeriesThursday, May 28, 2009, Part 3 of 3 Future developments in tumor tissue of origin testing and molecular oncology.Special guests: Dr. Federico Monzon, Medical Director of Molecular Diagnostics, at The Methodist Hospital in Houston and Dr. Shawn Becker, Pathwork Diagnostics’ Vice President of Marketing and Reimbursement. Future developments in tumor tissue of origin testing and molecular oncology.. For additional information about Pathwork Diagnostic's tumor tissue of origin test, see www.pathworkdx.com.
|
 |
Experts here are available to answer all your questions!
ADDITIONAL ONLINE RESOURCES |
 |
|